Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Kivu Bioscience Inc.
ViroMissile, Inc.
M.D. Anderson Cancer Center
Angiex, Inc.
MacroGenics
UNC Lineberger Comprehensive Cancer Center
Solve Therapeutics
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
IDRx Inc. - A GSK Company
M.D. Anderson Cancer Center
Kazia Therapeutics Limited
NextPoint Therapeutics, Inc.
IGM Biosciences, Inc.
University of California, San Francisco
Taiho Pharmaceutical Co., Ltd.
Sumitomo Pharma America, Inc.
National Cancer Institute (NCI)
Adaptimmune
Ipsen
Quadriga Biosciences, Inc.
Boston Scientific Corporation
Boston Scientific Corporation
GlaxoSmithKline
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Virginia Commonwealth University
BioMed Valley Discoveries, Inc
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
M.D. Anderson Cancer Center
Altor BioScience
National Cancer Institute (NCI)
Duke University
City of Hope Medical Center
Alaunos Therapeutics
Astellas Pharma Inc
Case Comprehensive Cancer Center
Pediatric Brain Tumor Consortium
National Institutes of Health Clinical Center (CC)